Cultivation and Production
At CINV, we painstakingly cultivate premium medical cannabis genetics optimized for therapeutic use. Our state-of-the-art facilities in South Africa allow us to oversee the entire seed to sale process, ensuring consistent quality and efficacy.
Our cultivation techniques produce exceptional cannabis flower with ideal structure, cannabinoid levels, terpene profiles, and flavor. We breed specialized varieties to access rare compounds for tailored cannabinoid profiles. Combining select terpenes and cannabinoids creates an entourage effect that enhances therapeutic benefits.
Our subsidiary Ember Pharms conducts breeding, propagation, preservation, and R&D at a licensed greenhouse facility. We plan to build an EU GMP certified indoor cultivation site to increase capacity up to 9,360 kg annually by 2026.
We partner with Pharma Africa for additional indoor cultivation, international distribution, and operational support. Their SAGMP certified facility uses our genetics to produce premium medical cannabis.
End-to-End Quality Control
By overseeing the entire seed to sale process, we ensure reliable potency, cannabinoid levels, and terpene profiles in every batch. Our non-irradiated approach retains the full spectrum of compounds for optimal patient relief.